NMTC vs TECH · rev $3.5M vs P/E 65, rev $1.22B
Neuroone Medical Technologies Corp (NMTC) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Neuroone Medical Technologies Corp (NMTC) is a medical devices company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported NMTC revenue for 2024-09-30 was $3.5M. Net income was -$12.3M. Revenue was up 76.9% from 2023-09-30 to 2024-09-30. NMTC currently screens at market cap $35.5M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
NMTC currently screens at market cap $35.5M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the NMTC and TECH stock pages for the full models.
Not investment advice.